antibiotics

by Uppsala University edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Tove Fall, principal investigator of the study, is holding one of the stool samples analyzed in the study. Credit: Sandra Gunnarsson Antibiotic treatments can affect the composition of the community of bacteria living in the gut, known as the […]

FEBRUARY 24TH, 2026POSTED BY BRIAN CONSIGLIO-U. MISSOURI Hongmin Sun holds up the spray-mist device. (Credit: Mizzou) SHARE THIS  ARTICLE Facebook   Twitter   Reddit   Email You are free to share this article under the Attribution 4.0 International license. TAGS ANTIBIOTICS MRSA UNIVERSITY UNIVERSITY OF MISSOURI New research unveils a safer, smarter way to fight drug-resistant

Robots can help develop them By Devika Rao, The Week US published yesterday Metallic medicine Robotic chemistry can be used to produce and test metal-based antibiotics, according to a study published in the journal Nature Communications. Most modern antibiotics are organic or carbon-based and tend to interact with bacteria in predictable ways. However, metal-containing compounds have a unique geometry

by Lancaster University edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes  The GIST Add as preferred source Graphical Abstract. Credit: Discovery Immunology (2025). DOI: 10.1093/discim/kyaf018 Research led by Lancaster University has discovered that a class of antibiotics—fluoroquinolones—can directly alter the potential bacterial killing ability of one of our immune cells called the macrophage. Our lungs must balance the

by Ahmed Elbediwy, Nadine Wehida, The Conversation edited by Gaby Clark, reviewed by Andrew Zinin  Editors’ notes Credit: Unsplash/CC0 Public Domain Many cancer survivors live with the worry that their cancer might come back. This “recurrence” occurs when cancer cells hide somewhere in the body—like in the bone marrow—and start growing again, sometimes years later. Scientists have been

Peer-Reviewed Publication University of Liverpool Scientists at the University of Liverpool, working with international collaborators, have discovered Novltex, a groundbreaking new class of antibiotics with potent activity against some of the world’s most dangerous multidrug-resistant (MDR) bacteria. The discovery, led by Dr Ishwar Singh, Reader in Antimicrobial Drug Discovery at the University of Liverpool, marks a

Newly identified compounds appear effective against drug-resistant bacteria. The technique used to reveal them could uncover many more antibiotics, as well as help illuminate a previously hidden microbial world. Peer-Reviewed Publication Rockefeller University image: To find bioactive molecules with the potential to become new drugs less prone to antibiotic resistance, the researchers sequenced bacterial DNA

TOPLINE: In a large cohort, long-acting lipoglycopeptides (laLGPs) demonstrated comparable effectiveness to standard-of-care antibiotics for step-down treatment of serious Gram-positive bacterial infections in both individuals who used drugs and those who did not. METHODOLOGY: Standard antibiotic therapy for serious bacterial infections can be challenging due to stigma and logistical barriers associated with prolonged treatment. LaLGPs